These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11242792)
1. Pathologic features of breast cancers in women with previous benign breast disease. Jacobs TW; Byrne C; Colditz G; Connolly JL; Schnitt SJ Am J Clin Pathol; 2001 Mar; 115(3):362-9. PubMed ID: 11242792 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease. Visscher DW; Frost MH; Hartmann LC; Frank RD; Vierkant RA; McCullough AE; Winham SJ; Vachon CM; Ghosh K; Brandt KR; Farrell AM; Tarabishy Y; Hieken TJ; Haddad TC; Kraft RA; Radisky DC; Degnim AC Cancer; 2016 Feb; 122(3):378-85. PubMed ID: 26512815 [TBL] [Abstract][Full Text] [Related]
3. Breast carcinoma in women 35 years and younger: a pathological study. Fernandopulle SM; Cher-Siangang P; Tan PH Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742 [TBL] [Abstract][Full Text] [Related]
4. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777 [TBL] [Abstract][Full Text] [Related]
5. An analysis of prognostic features in infiltrating lobular carcinoma of the breast. Frost AR; Terahata S; Yeh IT; Siegel RS; Overmoyer B; Silverberg SG Mod Pathol; 1995 Oct; 8(8):830-6. PubMed ID: 8552571 [TBL] [Abstract][Full Text] [Related]
6. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983 [TBL] [Abstract][Full Text] [Related]
7. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma? Sullivan PS; Apple SK Breast J; 2009; 15(2):146-54. PubMed ID: 19292800 [TBL] [Abstract][Full Text] [Related]
8. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887 [TBL] [Abstract][Full Text] [Related]
9. Assessment of pathologic prognostic factors in breast core needle biopsies. Sharifi S; Peterson MK; Baum JK; Raza S; Schnitt SJ Mod Pathol; 1999 Oct; 12(10):941-5. PubMed ID: 10530557 [TBL] [Abstract][Full Text] [Related]
10. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study. Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution. Intra M; Rotmensz N; Viale G; Mariani L; Bonanni B; Mastropasqua MG; Galimberti V; Gennari R; Veronesi P; Colleoni M; Tousimis E; Galli A; Goldhirsch A; Veronesi U Cancer; 2004 Sep; 101(5):905-12. PubMed ID: 15329896 [TBL] [Abstract][Full Text] [Related]
12. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ Cancer; 2007 Jan; 109(2):180-7. PubMed ID: 17154175 [TBL] [Abstract][Full Text] [Related]
13. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Changsri C; Prakash S; Sandweiss L; Bose S Breast J; 2004; 10(5):392-7. PubMed ID: 15327491 [TBL] [Abstract][Full Text] [Related]
14. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [TBL] [Abstract][Full Text] [Related]
15. Fine-needle aspiration cytology findings of an uncommon micropapillary variant of pure mucinous carcinoma of the breast: review of patients over an 8-year period. Ng WK Cancer; 2002 Oct; 96(5):280-8. PubMed ID: 12378595 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Roger P; Sahla ME; Mäkelä S; Gustafsson JA; Baldet P; Rochefort H Cancer Res; 2001 Mar; 61(6):2537-41. PubMed ID: 11289127 [TBL] [Abstract][Full Text] [Related]
17. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry]. Masiuk M Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394 [TBL] [Abstract][Full Text] [Related]
18. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
19. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492 [TBL] [Abstract][Full Text] [Related]
20. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature. Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]